Cargando…

Survival Outcomes and Predictors for Patients who Failed Chemoradiotherapy/Radiotherapy and Underwent Salvage Total Laryngectomy

Background: To assess the presence of adverse pathological features at the time of salvage total laryngectomy (TL) associated with oncologic outcome. Methods: Ninety patients with persistent/locally recurrent disease and who subsequently underwent salvage TL after definitive treatment by radiation a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Ming-Hsien, Chuang, Hui-Ching, Lin, Yu-Tsai, Huang, Tai-Lin, Fang, Fu-Min, Lu, Hui, Chien, Chih-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825052/
https://www.ncbi.nlm.nih.gov/pubmed/33418958
http://dx.doi.org/10.3390/ijerph18020371
_version_ 1783640220173860864
author Tsai, Ming-Hsien
Chuang, Hui-Ching
Lin, Yu-Tsai
Huang, Tai-Lin
Fang, Fu-Min
Lu, Hui
Chien, Chih-Yen
author_facet Tsai, Ming-Hsien
Chuang, Hui-Ching
Lin, Yu-Tsai
Huang, Tai-Lin
Fang, Fu-Min
Lu, Hui
Chien, Chih-Yen
author_sort Tsai, Ming-Hsien
collection PubMed
description Background: To assess the presence of adverse pathological features at the time of salvage total laryngectomy (TL) associated with oncologic outcome. Methods: Ninety patients with persistent/locally recurrent disease and who subsequently underwent salvage TL after definitive treatment by radiation alone (RTO) or concurrent chemo-radiation (CCRT) from 2009 to 2018 were retrospectively enrolled. Kaplan–Meier methods were used to estimate overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS). Results: Lymphovascular invasion (LVI), perineural invasion, positive margin, and stage IV disease were associated with worse survival in the univariate analysis. In the multivariate analysis, the presence of LVI and positive margin were both independent negative predictors in OS (LVI: adjusted hazard ratio (aHR) = 2.537, 95% CI: 1.163–5.532, p = 0.019; positive margin: aHR = 5.68, 95% CI: 1.996–16.166, p = 0.001), DSS (LVI: aHR = 2.975, 95% CI: 1.228–7.206, p = 0.016); positive margin: aHR = 11.338, 95% CI: 2.438–52.733, p = 0.002), and DFS (LVI: aHR 2.705, 95% CI: 1.257–5.821, p = 0.011; positive margin (aHR = 6.632, 95% CI: 2.047–21.487, p = 0.002). Conclusions: The presence of LVI and positive margin were both associated with poor OS, DSS, and DFS among patients who underwent salvage TL after failure of RTO/CCRT. The role of adjuvant therapy for high-risk patients after salvage TL to improve the chance of survival requires more investigation in the future.
format Online
Article
Text
id pubmed-7825052
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78250522021-01-24 Survival Outcomes and Predictors for Patients who Failed Chemoradiotherapy/Radiotherapy and Underwent Salvage Total Laryngectomy Tsai, Ming-Hsien Chuang, Hui-Ching Lin, Yu-Tsai Huang, Tai-Lin Fang, Fu-Min Lu, Hui Chien, Chih-Yen Int J Environ Res Public Health Article Background: To assess the presence of adverse pathological features at the time of salvage total laryngectomy (TL) associated with oncologic outcome. Methods: Ninety patients with persistent/locally recurrent disease and who subsequently underwent salvage TL after definitive treatment by radiation alone (RTO) or concurrent chemo-radiation (CCRT) from 2009 to 2018 were retrospectively enrolled. Kaplan–Meier methods were used to estimate overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS). Results: Lymphovascular invasion (LVI), perineural invasion, positive margin, and stage IV disease were associated with worse survival in the univariate analysis. In the multivariate analysis, the presence of LVI and positive margin were both independent negative predictors in OS (LVI: adjusted hazard ratio (aHR) = 2.537, 95% CI: 1.163–5.532, p = 0.019; positive margin: aHR = 5.68, 95% CI: 1.996–16.166, p = 0.001), DSS (LVI: aHR = 2.975, 95% CI: 1.228–7.206, p = 0.016); positive margin: aHR = 11.338, 95% CI: 2.438–52.733, p = 0.002), and DFS (LVI: aHR 2.705, 95% CI: 1.257–5.821, p = 0.011; positive margin (aHR = 6.632, 95% CI: 2.047–21.487, p = 0.002). Conclusions: The presence of LVI and positive margin were both associated with poor OS, DSS, and DFS among patients who underwent salvage TL after failure of RTO/CCRT. The role of adjuvant therapy for high-risk patients after salvage TL to improve the chance of survival requires more investigation in the future. MDPI 2021-01-06 2021-01 /pmc/articles/PMC7825052/ /pubmed/33418958 http://dx.doi.org/10.3390/ijerph18020371 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tsai, Ming-Hsien
Chuang, Hui-Ching
Lin, Yu-Tsai
Huang, Tai-Lin
Fang, Fu-Min
Lu, Hui
Chien, Chih-Yen
Survival Outcomes and Predictors for Patients who Failed Chemoradiotherapy/Radiotherapy and Underwent Salvage Total Laryngectomy
title Survival Outcomes and Predictors for Patients who Failed Chemoradiotherapy/Radiotherapy and Underwent Salvage Total Laryngectomy
title_full Survival Outcomes and Predictors for Patients who Failed Chemoradiotherapy/Radiotherapy and Underwent Salvage Total Laryngectomy
title_fullStr Survival Outcomes and Predictors for Patients who Failed Chemoradiotherapy/Radiotherapy and Underwent Salvage Total Laryngectomy
title_full_unstemmed Survival Outcomes and Predictors for Patients who Failed Chemoradiotherapy/Radiotherapy and Underwent Salvage Total Laryngectomy
title_short Survival Outcomes and Predictors for Patients who Failed Chemoradiotherapy/Radiotherapy and Underwent Salvage Total Laryngectomy
title_sort survival outcomes and predictors for patients who failed chemoradiotherapy/radiotherapy and underwent salvage total laryngectomy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825052/
https://www.ncbi.nlm.nih.gov/pubmed/33418958
http://dx.doi.org/10.3390/ijerph18020371
work_keys_str_mv AT tsaiminghsien survivaloutcomesandpredictorsforpatientswhofailedchemoradiotherapyradiotherapyandunderwentsalvagetotallaryngectomy
AT chuanghuiching survivaloutcomesandpredictorsforpatientswhofailedchemoradiotherapyradiotherapyandunderwentsalvagetotallaryngectomy
AT linyutsai survivaloutcomesandpredictorsforpatientswhofailedchemoradiotherapyradiotherapyandunderwentsalvagetotallaryngectomy
AT huangtailin survivaloutcomesandpredictorsforpatientswhofailedchemoradiotherapyradiotherapyandunderwentsalvagetotallaryngectomy
AT fangfumin survivaloutcomesandpredictorsforpatientswhofailedchemoradiotherapyradiotherapyandunderwentsalvagetotallaryngectomy
AT luhui survivaloutcomesandpredictorsforpatientswhofailedchemoradiotherapyradiotherapyandunderwentsalvagetotallaryngectomy
AT chienchihyen survivaloutcomesandpredictorsforpatientswhofailedchemoradiotherapyradiotherapyandunderwentsalvagetotallaryngectomy